There's an art to creating - and selling - a life science company
Article Abstract:
The various things to be considered intelligently and quantitatively while starting or selling a life science company are discussed. A successful innovation that is in demand and can solve an existing problem is found to be the most important thing to start a company.
Publisher: Scientist Inc.
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2008
Management dynamics, Pharmaceutical preparations, Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Management, Pharmaceutical industry, Company business management, BioAdvance, BioRexis Pharmaceutical Corp., David, King, Kurtzman, Gary
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
A very expensive disease
Article Abstract:
The article discusses the several expenses associated with the treatment of schizophrenia, as most of the patients become unfit for work. New employment and financial programs need to be developed to render help to the patients.
Publisher: Scientist Inc.
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2007
United States, Financial management, Health aspects, Care and treatment, Finance, Schizophrenia, Schizophrenics, Company financing, Federal aid to community health services, Government aid to community health services
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.